This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adachi, W., et al., 1998, Isolation and characterization of human cathepsin V: A major proteinase in corneal epithelium. Invest. Ophthalmol. Vis. Sci. 39: 1789–1796.
Albe, K., et al., 1996, Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol. Pharm. Bull. 19: 1026–1031.
Berti, P. J., and Storer, A. C., 1995, Alignment/phylogeny of the papain superfamily of cysteine proteases. J. Mol. Biol. 246: 273–283.
Brömme, D., et al., 1999, Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry 38: 2377–2385.
Brömme, D., and Okamoto, K., 1995, Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol. Chem. Hoppe Seyler 376: 379–384.
Brömme, D., et al., 1996, Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J. Biol. Chem. 271: 2126–2132.
Brown, J., et al., 1998, Lymphopain, a cytotoxic T and natural killer cell-associated cysteine proteinase. Leukemia 12: 1771–1781.
Bühling, F., et al., 1999, Expression of cathepsin K in lung epithelial cells. Am. J. Cell Mol. Biol. 20: 612–619.
Carmona, E., et al., 1996, Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry 35: 8149–8157.
Chapman, H.A., et al., 1997, Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59: 63–88.
Cygler, M., and Mort, J. S., 1997, Proregion structure of members of the papain superfamily. Mode of inhibiton of enzymatic activity. Biochimie 79: 645–652.
Docherty, K., et al., 1982, Conversion of proinsulin to insulin: involvement of a 31, 500 molecular weight thiol protease. Proc. Natl. Acad. Sei. 79: 4613–4617.
Dodds, R. A., et al., 1999, Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues. Arthritis Rheum. 42: 1588–1593.
Fengler, A., and Brandt, W., 1998, Three Dimensional Structures of the Cysteine Proteases Cathepsin K and S Deduced by Knowledge-Based Modelling and Active Site Characteristics. Prot. Eng. 11: 1007–1013.
Figueiredo-Pereira, M. E., et al., 1999, Distinct secretases, a cysteine protease and a serine protease, generate the C termini of amyloid beta-proteins Abetal-40 and Abetal-42, respectively. J. Neurochem. 72: 1417–1422.
Fox, T., et al., 1992, Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry 31: 12571–12576.
Garnero, P., et al., 1998, The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem. 273: 32347–32352.
Gay, N. J., and Walker, J. E., 1985, Molecular cloning of a bovine cathepsin. Biochem. J. 225: 707–712.
Gelb, B. D., et al., 1996, Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273: 1236–1238.
Gelb, B. D., et al., 1997, Structure and chromosomal assignment of the human cathepsin K gene. Genomics 41: 258–262.
Groves, M. R., et al., 1998, Structural basis for specificity of papain-like cysteine protease proregions toward their cognate enzymes Proteins 32: 504–514.
Häckel, C., et al., 1999, Expression of cathepsin K in the human embryo and fetus. Dev. Dyn. 216: 89–95.
Hummel, K. M., et al., 1998, Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J. Rheumatol 25: 1887–1894.
Inaoka, T., et al., 1995, Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. Biochem. Biophys. Res. Commun. 206: 89–96.
Inui, T., et al., 1997, Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J. Biol. Chem. 272: 8109–8112.
Kafienah, W., et al., 1998, Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem. J. 331: 727–732.
Katunuma, N., and Kominami, E., 1987, Abnormalexpression of lysosomal cysteine proteinases in muscle wasting diseases, Rev. Physiol. Biochem. Pharmacol. 108: 1–20.
Kirschke, H., and Barrett, A. J., 1987, In Lysosomes: their role in protein breakdown (H. Glaumann, and F. J. Ballard, eds.), Academic Press, London pp. 193–238.
Lemere, C. A., et al., 1995, The lysosomal cysteine protease, cathepsin S, is increased in Alzhenner’s disease and Down syndrome brain. An immunocytochemical study. Am. J. Pathol. 146: 848–860.
LaLonde, J.M., et al., l998, Use of papain as a model for the structure-based design of cathepsin K inhibitors: Crystal structures of two papain-inhibitor complexes demonstrate binding to S’-subsites. J. Med. Chem. 41: 4567–4576.
Linnevers, C., et al., 1997, Human cathepsin W, a putative cysteine protease predominantly expressed in CD8+ T-lymphocytes. FEBS Letters 405: 253–259.
Littlewood-Evans, A., et al., 1997a, Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20: 81–86.
Littlewood-Evans, A.J., et al., 1997b, The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res. 57: 5386–5390.
Mach, L., et al., 1994, Noncovalent complexes between the lysosomal proteinase cathepsin B and its propeptide account for stable, extracellular, high molecular mass forms of the enzyme. J. Biol. Chem. 269: 13036–13040.
Maubach, G., et al., 1997, The inhibition of cathepsin S by its propeptide-specificity and mechanism of action. Eur. J. Biochem. 250: 745–750.
McGrath, M.E., et al., 1997, Crystal structure of human cathepsin K complexed with a potent inhibitor. Nature Struct. Biol. 4: 105–109.
Mort, J.S., et al., 1984, Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthr. Rheum. 27: 509–515.
Nägler, D.K., and Ménard, R., 1998, Human cathepsin X: A novel cysteine protease of the papain family with a very short proregion and unique insertions. FEBS Lett. 434: 135–139.
Nägler, D.K., et al., 1999a, Full-length cDNA of human cathepsin F predicts the presence of a cystatin domain at the N-terminus of the cysteine protease zymogen. Biochem. Biophys. Res. Commun. 257: 313–318.
Nägler, D.K., et al., 1999b, Interdependency of sequence and positional specificities for cysteine proteases of the papain family. Biochemistry 38: 4868–4874.
Nägler, D.K., et al., 1999c, Human cathepsin X: A cysteine protease with unique carboxypeptidase activity. Biochemistry 39: 12648–12654.
Nakagawa, T., et al., 1998, Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280: 450–453
Riese, R.J., et al., 1996, Essential role for cathepsin S in MHC class-associated invariant chain processing and peptide loading. Immunity 4: 357–366.
Saftig, P., et al., 1998, Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. 95: 13453–13458.
Samarel, A.M., et al., 1989, Effects of cysteine protease inhibitors on rabbit cathepsin D maturation. Am. J. Physiol 257: 1069–1079.
Santamaría, I., et al., 1998a, Genomic structure and chromosomal localization of the human cathepsin gene (CTSO). Genomics 53: 231–234.
Santamaría, I., et al., 1998b, Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas. Cancer Res. 58: 1624–1630.
Santamaría, I., et al., 1998c, Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and a unique chromosomal location. J. Biol. Chem. 273: 16816–16823.
Santamaria, I., et al., 1999, Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain. J. Biol. Chem. 274: 13800–13809.
Shi, G.P., et al., 1995, Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett. 357: 129–134.
Sivaraman, et al., 1999, Crystal structure of wild-type human procathepsin K. Protein Sci. 8: 283–290.
Sloane, B.F., et al., 1981, Lysosomal cathepsin B: correlation with metastatic potential. Science 212: 1151–1153.
Sloane, B.F., and Honn, K.V., 1984, Cysteine proteinases and metastasis. Cancer Metastasis Rev. 3: 249–263.
Smith, W.W., and Abdelmeguid, S.S., 1999, Cathepsin K as a target for the treatment of osteoporosis. Expert Opin. Ther. Patents 9: 683–694.
Sol-Church, K., et al., 1999, Cathepsin P, a novel protease in mouse placenta. Biochem. J. 343: 307–309.
Stenman, G., et al., 1997, Assignment of a novel cysteine proteinase inhibitor (CST6) to 11q13 by fluorescence in situ hybridization Cytogenet. Cell Genet. 76: 45–46.
Storer, A.C., and Ménard, R., 1996, Recent insights into cysteine protease specificity: Lessons for drug design. Perspect. Drug Discovery Des. 6: 33–46.
Stubbs, M.T., et al., 1990, The refined 2. 4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J. 9: 1939–1947.
Tao, K., et al., 1994, The proregion of cathepsin L is required for proper folding, stability, and ER exit. Arch. Biochem. Biophys. 311: 19–27.
Tezuka, K., et al., 1994, Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem. 269: 1106–1109.
Tisljar, K., et al., 1999, Cathepsin J, a novel murine cysteine protease of the papain family with a placenta-restricted expression. FEBS Lett 459: 299–304.
Turk, B, et al., 1997, Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol. Chem. 378: 141–150.
Turk, D., et al., 1998, Revised definition of substrate binding sites of papain-like cysteine proteases. Biol. Chem. 379: 137–147.
Velasco, J., et al., 1994, Human cathepsin O. Molecular cloning from a breast carcinoma, production of the active enzyme in Escherichia coli, and expression analysis in human tissues. J. Biol. Chem. 269: 27136–27142.
Wang, B., et al., 1998, Human cathepsin F. J. Biol. Chem. 273: 32000–32008.
Wex, T., et al., 1999, Human cathepsins F and W: A new subgroup of cathepsins. Biochem. Biophys. Res. Commun. 259: 401–407.
Wex, T., et al., 1998, Structure and chromosomal localization of the human cathepsin W-gene. Biochem. Biophys. Res. Commun. 248: 255–261.
Yamashita, D.S., et al., 1997, Structure and design of potent and selective cathepsin inhibitors. J. Am. Chem. Soc. 119: 11351–11352.
Zhao, B.G., et al., 1997, Crystal structure of human osteoclast cathepsin K complex with E-64. Nature Struct. Biol. 4: 109–111.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bühling, F., Fengler, A., Brandt, W., Welte, T., Ansorge, S., Nagler, D.K. (2002). Review: Novel Cysteine Proteases of the Papain Family. In: Langner, J., Ansorge, S. (eds) Cellular Peptidases in Immune Functions and Diseases 2. Advances in Experimental Medicine and Biology, vol 477. Springer, Boston, MA. https://doi.org/10.1007/0-306-46826-3_26
Download citation
DOI: https://doi.org/10.1007/0-306-46826-3_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46383-9
Online ISBN: 978-0-306-46826-1
eBook Packages: Springer Book Archive